Dectova
What Dectova is used for
Dectova is indicated for the treatment of complicated and potentially life-threatening influenza A or B virus infection in adult and paediatric patients (aged … (the exact criteria are in the official EMA product information).
Approved use, as published by the European Medicines Agency.
What the labels mean
- Approved under exceptional circumstances: full data cannot be collected, usually because the disease is very rare.
Key facts
- Brand
- Dectova
- Active substance
- zanamivir
- Disease area
- Influenza, Human
- Medicine group
- Antivirals for systemic use
- ATC code
- J05AH01
- Marketing authorisation holder
- GlaxoSmithKline Trading Services Limited
- Authorised in the EU since
- 2019
Official information
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Dectova used for?
Dectova is indicated for the treatment of complicated and potentially life-threatening influenza A or B virus infection in adult and paediatric patients (aged … (the exact criteria are in the official EMA product information).
What is the active substance in Dectova?
Dectova contains zanamivir.
Who makes Dectova?
The EU marketing authorisation holder is GlaxoSmithKline Trading Services Limited.
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU